This podcast is a recording of a live #MedComms webinar.
Artificial Intelligence (AI) technology is not new. Debates have been had for some time about, for instance, the possibilities to replace medical writers! Is it so difficult to imagine? Maybe. Maybe no.
ChatGPT is a new chatbot launched by OpenAI in November 2022 that has created a huge amount of interest. It answers questions and writes articles with apparent ease. And does so stunningly fast. Try it and you may be startled by what you get back....
This podcast is a recording of a live #MedComms webinar.
Artificial Intelligence (AI) technology is not new. Debates have been had for some time about, for instance, the possibilities to replace medical writers! Is it so difficult to imagine? Maybe. Maybe no.
ChatGPT is a new chatbot launched by OpenAI in November 2022 that has created a huge amount of interest. It answers questions and writes articles with apparent ease. And does so stunningly fast. Try it and you may be startled by what you get back. However, it’s also been shown to produce some quite daft results! So just how accurate is it, or could it be? What are the source materials? How ‘good’ is the writing? Is it a tool that supports a human writer or will it – might it – replace them? Will it matter to the reader? What unintended consequences might crop up?
In this webinar we are joined by Martin Delahunty (Inspiring STEM Consulting), Katja Martin (medtextpert), Stephen Mott (PharmAdvisor) and Avishek Pal (Novartis) for an informal discussion about the possible implementations within and around MedComms. None are experts in AI, but all have played with ChatGPT and are thinking about the impact on the work we do.
It should be of interest to anyone who is working in and around MedComms, or who is wanting to join the business.
Recorded 19 January 2023 as a MedComms Networking webinar. Produced by NetworkPharma.tv
= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
Martin’s LinkedIn page is at https://www.linkedin.com/in/martindelahunty/
Katja’s LinkedIn page is at https://www.linkedin.com/in/katja-martin/
Stephen’s LinkedIn page is at https://www.linkedin.com/in/smott/
Avishek’s LinkedIn page is at https://www.linkedin.com/in/avishek-pal-cmpp-99921516/
You’ll find ChatGPT at https://openai.com/blog/chatgpt/
Some further information (IMPORTANT note there is so much out there and developments are coming so fast, this can only be a tiny taste)
Video posted 18 January 2023: Generative AI & ChatGPT for Pharma at https://youtu.be/HxiDMvn9YT0
Article in Nature, published 18 January 2023, ChatGPT listed as author on research papers: many scientists disapprove at https://www.nature.com/articles/d41586-023-00107-z
LinkedIn article from Stephen Mott posted 13 January 2023: chatGPT – is a revolution heading this way for medicine and medical information? at https://www.linkedin.com/pulse/chatgpt-revolution-heading-way-medicine-medical-information-mott/
Article in The Scholarly Kitchen, published 11 January 2023, Thoughts on AI’s Impact on Scholarly Communications? An Interview with ChatGPT at https://scholarlykitchen.sspnet.org/2023/01/11/chatgpt-thoughts-on-ais-impact-on-scholarly-communications/
Article in The Spectator published 10 January 2023: AI is the end of writing at https://www.spectator.co.uk/article/ai-is-the-end-of-writing/
Blog from Katja Martin, published 10 December 2022: Should ChatGPT be in every medical communicator’s toolbox? at https://www.medtextpert.com/chatgpt-for-medical-communications/
= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
We are building a library of free video recordings for a global pharmaceutical industry audience at NetworkPharma.tv and we’d welcome your suggestions for new topics and speakers.
